LOS ANGELES (PRWEB) DECEMBER 11, 2019 Circularity is partnering with Telly...Read More
Products on this website for prescription (Rx) for U.S. residents only.
When seeking advanced wound care treatments regularly, D’OXYVA® (deoxyhemoglobin vasodilator) improves microcirculation and promotes the blood flow in the smallest blood vessels to deliver important nutrients and oxygen to organs and cells, which in turn supports the body’s own self-healing powers, enabling you to be active again.
Clinical studies with D’OXYVA have shown extraordinary results for the role of transdermal noninvasive and advanced wound therapy using ultra-purified, nontoxic, FDA-cleared molecules, such as CO2, especially when all other approaches failed.
In an ongoing multiyear, multi-country, multicenter, randomized clinical trial on patients with diabetic foot ulcers, D’OXYVA has demonstrated speeding up diabetic wound healing and ultimately wound closure to an average of 5 weeks though advanced wound management**.
Globally renowned healthcare experts share their D’OXYVA review.
IMPROVING QUALITY OF LIFE
Under Circularity’s Center of Excellence (COE) and Center of Profit (COP) programs, we provide short-, and long-term equipment finance with zero interest and/or complete complimentary marketing support and training for private clinics, even in combination with third party therapies and diagnostics.*
We finance your equipment and finance, design and implement your marketing campaigns so you’ll attract more new customers and treat more patients more affordably and faster than ever before.
Circularity’s financing programs were designed for all kinds of situations and equipment and harness the speed and accuracy of the latest fintech. Circularity provides unmatched convenience and industry-leading support to our customers nationwide and internationally.